Curcumin is a promising adjuvant therapy to suppress diabetes-induced spinal cord microglial activation, astrocytosis, and neuronal apoptosis through regulation of the Nrf2/HO-1 and NF-kB signaling pathways. Here, NFE2L2 is linked to diabetes mellitus.